Neurology

Multiple sclerosis affects nearly 3 million patients worldwide; new research is helping pave the way…

The chief medical officer at Immunic provided clinical insight on the dual mechanism of action…

David Devos, MD, PhD, a neuropharmacologist at the University of Lille, in France, discussed positive…

The chief medical officer at Edgewise Therapeutics gave an overview of the mechanism of EDG-5506,…

Fumihiko Urano, MD, PhD, principal investigator of the phase 2 HELIOS trial, discussed some of…

The senior scientist at Sunnybrook Research Institute talked about both the opportunities and challenges with…

In our latest roundtable series, experts highlighted research showing that even mild COVID can result…

Dr. Isaacson discusses how health care providers can effectively balance the pharmacological properties of approved…

The professor of neurology at NYU Grossman School of Medicine provided clinical insight on the…

Based on the positive data, the company plans to begin a phase 3 trial assessing…